JMV 3008 is a GHS-R1a antagonist with an IC 50 of 5.6 nM. JMV 3008 can be used in the research of diseases such as diabetes and obesity.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GHSR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。